Skin Cancer - Basal and Squamous Cell

FDA Requires Warning on Tanning Beds

The US Food and Drug Administration (FDA) says people under age 18 should not use tanning booths/beds or sunlamps, and these products will now have to carry a warning stating that. These devices have been re-classified as moderate risk (Class II) instead of low risk (Class I).

FDA Approves Drug for Basal Cell Carcinoma

The US Food and Drug Administration (FDA) has approved the first drug specifically for basal cell carcinoma, the most common type of skin cancer. The drug is called vismodegib (Erivedge)

Non-melanoma Skin Cancer Linked to Risk of Other Cancers

A study published in the Journal of the National Cancer Institute found that people with a history of basal or squamous cell skin cancer (also known as non-melanoma skin cancer) were at an increased risk of developing other cancers later on.